Nature | Trend Watch

US grants for zebrafish studies on the rise

Analysis from US National Institutes of Health charts shift in model-organism trends.

Article tools

Rights & Permissions

Uri Manor/NICHD

A zebrafish facility at the US National Institutes of Health in Bethesda, Maryland.

Zebrafish are the rising stars of model-organism research, an analysis of grants from the US National Institutes of Health (NIH) shows.
 
A team at the NIH Office of Portfolio Analysis assessed trends in the agency’s funding of model-organism research between 2008 and 2015, through its R01 awards, the largest NIH grant programme for individual investigators. Using a text-mining algorithm and manual searches, they studied grant data for four animal models: fruit flies (Drosophila melanogaster), nematode worms (Caenorhabditis elegans), zebrafish (Danio rerio) and Xenopus laevis frogs. Together these organisms were mentioned in more than 9,500 successful grant applications.
 
The analysis revealed that grants for zebrafish studies accounted for 0.8% of all R01 awards in 2008, but for 1.27% in 2015 — a rise of almost 60%. And the proportion of C. elegans studies rose from 0.87% to 0.98%, a more modest overall increase of about 36%. By contrast, awards for research with Xenopus frogs dropped by some 30%, from 0.83% to 0.57%.


 
The shifts are broadly representative of the numbers of applications received, the team says, indicating a shift in model-organism trends.
 
In an extension of the analysis, the team found that nearly 50% of funded R01 grants in the same period were for mouse studies — a proportion that has increased yearly since 2008.

Journal name:
Nature
DOI:
doi:10.1038/nature.2016.20391

For the best commenting experience, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will see comments updating in real-time and have the ability to recommend comments to other users.

Comments for this thread are now closed.

Comments

Comments Subscribe to comments

There are currently no comments.

sign up to Nature briefing

What matters in science — and why — free in your inbox every weekday.

Sign up

Listen

new-pod-red

Nature Podcast

Our award-winning show features highlights from the week's edition of Nature, interviews with the people behind the science, and in-depth commentary and analysis from journalists around the world.